Compare MDU Resources Group Inc. Common Stock (Holding Company) (MDU) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MDU Resources Group Inc. Common Stock (Holding Company) vs Oruka Therapeutics Inc. Common Stock — how do they compare? MDU Resources Group Inc. Common Stock (Holding Company) trades at $18.56 (market cap $3.90B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and MDU Resources Group Inc. Common Stock (Holding Company) pays a 3.05% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MDU Resources Group Inc. Common Stock (Holding Company) for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MDU | ORKA | |
|---|---|---|
Market Cap | $3.90B | $5.08B |
Volume | 1,134,084 | 685,276 |
Sector | Utilities | Health |
52-Week High | $22.80 | $113.08 |
52-Week Low | $18.39 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.43B | $4.21B |
Dividend Yield | 3.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MDU Resources Group Inc. Common Stock (Holding Company)
MDU Resources Group, Inc. is a US holding company operating regulated electric and natural gas utility services alongside a construction materials and services business supplying asphalt, concrete, and aggregates.
Read more on MDU →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
